Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Marschner

Showing results (41-50 of 71) with videos related to

Pageof 8
Sort By:
Journal of Medicinal Chemistry|May 1, 2023
Development of a Potent Nurr1 Agonist Tool for In Vivo ApplicationsJan Vietor, Christian Gege, Tanja Stiller, et al.
Journal of Medicinal Chemistry|June 3, 2026
An Activator of Tailless' Repressor Function Stimulates Anti-Neurodegenerative Gene ExpressionEmily C Hank, Romy Busch, Úrsula López-García, et al.
Journal of Medicinal Chemistry|September 26, 2023
Structure-Guided Design of Nurr1 Agonists Derived from the Natural Ligand DihydroxyindoleMinh Sai, Jan Vietor, Moritz Kornmayer, et al.
ACS Medicinal Chemistry Letters|April 16, 2025
Fragment-Based Discovery of Drug-like LRH-1 AgonistsAlisa Lang, Niklas Ildefeld, Felix F Lillich, et al.
Radiology. Cardiothoracic Imaging|December 11, 2023
Combined FDG PET/MRI versus Standard-of-Care Imaging in the Evaluation of Cardiac SarcoidosisConstantin A Marschner, Faisal Aloufi, Matthew Aitken, et al.
Nature Communications|June 18, 2024
Chemogenomics for NR1 nuclear hormone receptorsLaura Isigkeit, Espen Schallmayer, Romy Busch, et al.
Journal of Medicinal Chemistry|January 18, 2024
Structure-Guided Design of a Highly Potent Partial RXR Agonist with Superior Physicochemical PropertiesMax Lewandowski, Melania Carmina, Loris Knümann, et al.
Angewandte Chemie (International Ed. in English)|May 11, 2026
An Agonist/Antagonist Photo-Switchable Vitamin D Mimetic Enables Bidirectional Optical Control of VDRXiu Ge, Sabine Willems, Francesco Melfi, et al.
Journal of Medicinal Chemistry|September 11, 2024
Tuning RXR Modulators for PGC1α RecruitmentFelix Nawa, Minh Sai, Jan Vietor, et al.
Journal of Medicinal Chemistry|May 8, 2025
A First-in-Class Hepatocyte Nuclear Factor 4 AgonistEspen Schallmayer, Vasily Morozov, Silke Duensing-Kropp, et al.
Pageof 8

Showing results (41-50 of 71) with videos related to

Sort By:
Pageof 8
Journal of Medicinal Chemistry|May 1, 2023
Development of a Potent Nurr1 Agonist Tool for In Vivo ApplicationsJan Vietor, Christian Gege, Tanja Stiller, et al.
Journal of Medicinal Chemistry|June 3, 2026
An Activator of Tailless' Repressor Function Stimulates Anti-Neurodegenerative Gene ExpressionEmily C Hank, Romy Busch, Úrsula López-García, et al.
Journal of Medicinal Chemistry|September 26, 2023
Structure-Guided Design of Nurr1 Agonists Derived from the Natural Ligand DihydroxyindoleMinh Sai, Jan Vietor, Moritz Kornmayer, et al.
ACS Medicinal Chemistry Letters|April 16, 2025
Fragment-Based Discovery of Drug-like LRH-1 AgonistsAlisa Lang, Niklas Ildefeld, Felix F Lillich, et al.
Radiology. Cardiothoracic Imaging|December 11, 2023
Combined FDG PET/MRI versus Standard-of-Care Imaging in the Evaluation of Cardiac SarcoidosisConstantin A Marschner, Faisal Aloufi, Matthew Aitken, et al.
Nature Communications|June 18, 2024
Chemogenomics for NR1 nuclear hormone receptorsLaura Isigkeit, Espen Schallmayer, Romy Busch, et al.
Journal of Medicinal Chemistry|January 18, 2024
Structure-Guided Design of a Highly Potent Partial RXR Agonist with Superior Physicochemical PropertiesMax Lewandowski, Melania Carmina, Loris Knümann, et al.
Angewandte Chemie (International Ed. in English)|May 11, 2026
An Agonist/Antagonist Photo-Switchable Vitamin D Mimetic Enables Bidirectional Optical Control of VDRXiu Ge, Sabine Willems, Francesco Melfi, et al.
Journal of Medicinal Chemistry|September 11, 2024
Tuning RXR Modulators for PGC1α RecruitmentFelix Nawa, Minh Sai, Jan Vietor, et al.
Journal of Medicinal Chemistry|May 8, 2025
A First-in-Class Hepatocyte Nuclear Factor 4 AgonistEspen Schallmayer, Vasily Morozov, Silke Duensing-Kropp, et al.
Pageof 8